PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients
Recruiting · NCT05704166 · Registry updated 2025-08-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients | Lung Injury, Neoplasms by Site, Skin and Connective Tissue Diseases, acute lung injury, breast disorder, breast neoplasm, lung disorder, neoplasm, respiratory system disorder, skin disorder | Recruiting | Phase 2 | 2025-08-08 | NCT05704166 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Continent Pharmaceutical Co, Ltd. | 8 |
| Fujian Medical University Union Hospital | 108 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fujian Medical University Union Hospital | Fuzhou | China | 38 |